| COVID-19 vaccine: where are we now and where should we go? S Soleimanpour, A Yaghoubi Expert review of vaccines 20 (1), 23-44, 2021 | 188 | 2021 |
| Bacteria and cancer: Different sides of the same coin G Laliani, SG Sorboni, R Lari, A Yaghoubi, S Soleimanpour, M Khazaei, ... Life sciences 246, 117398, 2020 | 48 | 2020 |
| Bacteria as a double-action sword in cancer A Yaghoubi, M Khazaei, S Jalili, SM Hasanian, A Avan, S Soleimanpour, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (1), 188388, 2020 | 43 | 2020 |
| The bacterial instrument as a promising therapy for colon cancer A Yaghoubi, M Khazaei, A Avan, SM Hasanian, S Soleimanpour International journal of colorectal disease 35, 595-606, 2020 | 40 | 2020 |
| Bacteriotherapy in gastrointestinal cancer S Soleimanpour, SM Hasanian, A Avan, A Yaghoubi, M Khazaei Life sciences 254, 117754, 2020 | 38 | 2020 |
| p28 bacterial peptide, as an anticancer agent A Yaghoubi, M Khazaei, A Avan, SM Hasanian, WC Cho, S Soleimanpour Frontiers in oncology 10, 1303, 2020 | 33 | 2020 |
| Cerium oxide nanoparticles acts as a novel therapeutic agent for ulcerative colitis through anti-oxidative mechanism F Asgharzadeh, A Hashemzadeh, F Rahmani, A Yaghoubi, SE Nazari, ... Life sciences 278, 119500, 2021 | 31 | 2021 |
| Bacteriotherapy in breast cancer A Yaghoubi, M Khazaei, SM Hasanian, A Avan, W C. Cho, ... International journal of molecular sciences 20 (23), 5880, 2019 | 30 | 2019 |
| Therapeutic effects of silver nanoparticle containing sulfasalazine on DSS-induced colitis model F Asgharzadeh, A Hashemzadeh, A Yaghoubi, A Avan, SE Nazari, ... Journal of Drug Delivery Science and Technology 61, 102133, 2021 | 27 | 2021 |
| An effective drug against COVID-19: reality or dream? A Yaghoubi, S Amel Jamehdar, A Movaqar, N Milani, S Soleimanpour Expert Review of Respiratory Medicine 15 (4), 505-518, 2021 | 20 | 2021 |
| Previous pulmonary tuberculosis enhances the risk of lung cancer: systematic reviews and meta-analysis H Abdeahad, M Salehi, A Yaghoubi, AH Aalami, F Aalami, ... Infectious Diseases 54 (4), 255-268, 2022 | 18 | 2022 |
| The prevalence of genes encoding ESBL among clinical isolates of Escherichia coli in Iran: A systematic review and meta-analysis RS Ghaderi, A Yaghoubi, R Amirfakhrian, SI Hashemy, K Ghazvini Gene Reports 18, 100562, 2020 | 16 | 2020 |
| Tuberculosis, human immunodeficiency viruses and TB/HIV co-infection in pregnant women: a meta-analysis A Yaghoubi, S Salehabadi, H Abdeahad, SM Hasanian, A Avan, ... Clinical Epidemiology and Global Health 8 (4), 1312-1320, 2020 | 14 | 2020 |
| The beneficial effect of combination therapy with sulfasalazine and valsartan in the treatment of ulcerative colitis F Asgharzadeh, A Yaghoubi, SE Nazari, A Hashemzadeh, SM Hasanian, ... EXCLI journal 20, 236, 2021 | 12 | 2021 |
| A century of attempts to develop an effective tuberculosis vaccine: Why they failed? S Soleimanpour, A Yaghoubi, FS Seddighinia, SAR Rezaee International Immunopharmacology 109, 108791, 2022 | 11 | 2022 |
| Evaluation of the therapeutic effect of melittin peptide on the ulcerative colitis mouse model A Yaghoubi, SA Jamehdar, MRA Eidgahi, K Ghazvini International Immunopharmacology 108, 108810, 2022 | 8 | 2022 |
| Designing and construction of a cloning vector containing mpt64 gene of Mycobacterium tuberculosis H Zare, E Aryan, S Alami, A Yaghoubi, R Teimourpour, Z Meshkat Tanaffos 17 (3), 198, 2018 | 8 | 2018 |
| Therapeutic effect of an anti-tuberculosis agent, isoniazid, and its nano-isoform in ulcerative colitis A Yaghoubi, J Davoodi, F Asgharzadeh, S Rezaie, E Nazari, M Khazaei, ... International Immunopharmacology 96, 107577, 2021 | 7 | 2021 |
| The use of Clostridium in cancer therapy: a promising way A Yaghoubi, K Ghazvini, M Khazaei, SM Hasanian, A Avan, ... Reviews and Research in Medical Microbiology 33 (2), 121-127, 2022 | 6 | 2022 |
| Peptides with Dual Antimicrobial-Anticancer Activity Derived from the N-terminal Region of H. pylori Ribosomal Protein L1 (RpL1) A Yaghoubi, M Khazaei, K Ghazvini, A Movaqar, A Avan, SM Hasanian, ... International Journal of Peptide Research and Therapeutics 27, 1057-1067, 2021 | 6 | 2021 |
